Terug
47
50
Dagbereik
€ 61,50
€ 62,85
52-Weeksbereik
€ 47,50
€ 82,22
Volume
1.214.484
50D / 200D Gem.
€ 71,41
/
€ 66,89
Vorige Slotkoers
€ 62,86
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 23,1 | 0,4 |
| P/B | 150,0 | 2,9 |
| ROE % | 153,6 | 3,9 |
| Net Margin % | 22,7 | 3,8 |
| Rev Growth 5Y % | 33,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 76,14
+22.7%
Low: € 56,00
High: € 94,00
Forward K/W
7,84
Forward WPA
€ 8,02
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,76B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 8,61
€ 8,41 – € 8,77
|
1,78B | 1 |
| FY2029 |
€ 9,53
€ 9,32 – € 9,71
|
1,92B | 1 |
| FY2028 |
€ 10,94
€ 10,71 – € 11,17
|
2,14B | 2 |
No quarterly estimates available
Dividend History
Yield
0,00%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 33,23% annually over 5 years — strong growth
Earnings declined -28,64% over the past year
ROE of 153,59% indicates high profitability
Net margin of 22,69% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 644,59M in free cash flow
Groei
Revenue Growth (5Y)
33,23%
Revenue (1Y)37,55%
Earnings (1Y)-28,64%
FCF Growth (3Y)31,41%
Kwaliteit
Return on Equity
153,59%
ROIC1254,19%
Net Margin22,69%
Op. Margin58,45%
Veiligheid
Debt / Equity
0,00
Current Ratio4,66
Interest Coverage45,03
Waardering
P/E Ratio
23,11
Forward P/EN/A
P/B Ratio149,99
EV/EBITDA8,81
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 37,55% | Revenue Growth (3Y) | 29,78% |
| Earnings Growth (1Y) | -28,64% | Earnings Growth (3Y) | 6,08% |
| Revenue Growth (5Y) | 33,23% | Earnings Growth (5Y) | -5,82% |
| Profitability | |||
| Revenue (TTM) | 1,40B | Net Income (TTM) | 316,89M |
| ROE | 153,59% | ROA | 12,55% |
| Gross Margin | 78,13% | Operating Margin | 58,45% |
| Net Margin | 22,69% | Free Cash Flow (TTM) | 644,59M |
| ROIC | 1254,19% | FCF Growth (3Y) | 31,41% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 4,66 |
| Interest Coverage | 45,03 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 23,11 | Forward P/E | N/A |
| P/B Ratio | 149,99 | P/S Ratio | 5,24 |
| PEG Ratio | -1,04 | Forward PEG | N/A |
| EV/EBITDA | 8,81 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 8,80% | ||
| Market Cap | 7,32B | Enterprise Value | 7,19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,40B | 1,02B | 829,25M | 660,12M | 443,31M |
| Net Income | 316,89M | 444,09M | 281,59M | 202,13M | 402,71M |
| EPS (Diluted) | 2,56 | 3,43 | 2,10 | 1,44 | 2,74 |
| Gross Profit | 1,09B | 855,91M | 636,89M | 520,81M | 361,90M |
| Operating Income | 816,29M | 551,48M | 337,57M | 267,53M | 275,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,53B | 2,06B | 1,73B | 1,84B | 1,10B |
| Total Liabilities | 2,48B | 1,70B | 1,65B | 1,67B | 907,48M |
| Shareholders' Equity | 48,81M | 363,82M | 83,81M | 169,80M | 196,95M |
| Total Debt | 0,0 | 1,51B | 1,50B | 1,51B | 876,67M |
| Cash & Equivalents | 133,82M | 115,85M | 118,37M | 234,20M | 118,72M |
| Current Assets | 825,21M | 1,09B | 746,42M | 739,01M | 926,29M |
| Current Liabilities | 177,09M | 139,10M | 112,49M | 130,79M | 117,15M |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#461 of 1052
Custom
Capital Light Compounder
#66 of 218
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026